Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒Yes☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒Yes☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated ~~filer,”~~filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of ~~April 5, 2022,~~January 3, 2023, there were outstanding ~~11,608,236~~12,022,371 shares of Common Stock, $0.05 par value and ~~2,053,263~~2,052,313 shares of Class B Common Stock, $0.05 par value, which are convertible into Common Stock of the registrant on a share for share basis.


	Unaudited		Audited		Unaudited			Audited
	February 26, 2022		May 29, 2021		November 26, 2022			May 28, 2022
Assets
Current assets:
Cash and cash equivalents	$	39,147	$	43,316	$	26,106		$	35,495
Accounts receivable, less allowance of $149 and $202, respectively		31,605		25,096
Accounts receivable, less allowance of $178 and $186, respectively						34,880			29,878
Inventories, net		73,673		63,508		97,434			80,390
Prepaid expenses and other assets		3,362		2,385		2,521			2,448
Investments - current						5,000			5,000
Total current assets		147,787		134,305		165,941			153,211
Non-current assets:
Property, plant and equipment, net		16,839		17,067		17,964			16,961
Intangible assets, net		2,077		2,270		2,025			2,010
Lease ROU asset		3,502		2,570		2,527			3,239
Other non-current assets						302			—
Non-current deferred income taxes		481		541		4,342			4,398
Total non-current assets		22,899		22,448		27,160			26,608
Total assets	$	170,686	$	156,753	$	193,101		$	179,819
Liabilities
Current liabilities:
Accounts payable	$	20,744	$	16,979	$	24,603		$	23,987
Accrued liabilities		15,975		14,182		17,074			16,110
Lease liability current		1,164		1,066		1,015			1,109
Total current liabilities		37,883		32,227		42,692			41,206
Non-current liabilities:
Non-current deferred income tax liabilities		235		242		83			85
Lease liability non-current		2,113		1,358		1,512			1,915
Other non-current liabilities		844		1,366		726			766
Total non-current liabilities		3,192		2,966		2,321			2,766
Total liabilities		41,075		35,193		45,013			43,972
Stockholders’ Equity
Common stock, $0.05 par value; issued and outstanding 11,608 shares on February 26, 2022 and 11,160 shares on May 29, 2021		580		558
Class B common stock, convertible, $0.05 par value; issued and outstanding 2,053 shares on February 26, 2022 and 2,097 shares on May 29, 2021		103		105
Preferred stock, $1.00 par value, 0 shares issued		—		—
Common stock, $0.05 par value; issued and outstanding 12,022 shares on November 26, 2022 and 11,649 shares on May 28, 2022						601			582
Class B common stock, convertible, $0.05 par value; issued and outstanding 2,052 shares on November 26, 2022 and 2,053 shares on May 28, 2022						103			103
Preferred stock, $1.00 par value, no shares issued						—			—
Additional paid-in-capital		65,831		62,707		69,669			66,331
Retained earnings		60,557		53,297		78,254			68,031
Accumulated other comprehensive income		2,540		4,893
Accumulated other comprehensive (loss) income						(539	)		800
Total stockholders’ equity		129,611		121,560		148,088			135,847
Total liabilities and stockholders’ equity	$	170,686	$	156,753	$	193,101		$	179,819


	Three Months Ended						Nine Months Ended						Three Months Ended						Six Months Ended
	February 26, 2022			February 27, 2021			February 26, 2022			February 27, 2021			November 26, 2022			November 27, 2021			November 26, 2022			November 27, 2021
Net sales	$	55,308		$	45,235		$	162,991		$	126,465		$	65,905		$	53,979		$	133,462		$	107,683
Cost of sales		37,739			29,469			111,468			83,997			44,054			36,322			88,584			73,729
Gross profit		17,569			15,766			51,523			42,468			21,851			17,657			44,878			33,954
Selling, general and administrative expenses		13,946			15,457			40,550			41,924			14,677			13,135			28,925			26,604
Loss (gain) on disposal of assets		—			(6	)		2			(6	)
(Gain) loss on disposal of assets														(25	)		2			(25	)		2
Operating income		3,623			315			10,971			550			7,199			4,520			15,978			7,348
Other expense (income):
Investment/interest income		(11	)		(15	)		(36	)		(48	)		(78	)		(8	)		(103	)		(25	)
Foreign exchange loss (gain)		121			65			(2	)		650
Foreign exchange loss														223			(150	)		597			(123	)
Other, net		17			(25	)		39			(61	)		(13	)		6			(15	)		22
Total other expense		127			25			1			541
Total other expense (income)														132			(152	)		479			(126	)
Income before income taxes		3,496			290			10,970			9			7,067			4,672			15,499			7,474
Income tax provision		609			62			1,326			239			1,518			550			3,626			717
Net income (loss)		2,887			228			9,644			(230	)
Net income														5,549			4,122			11,873			6,757
Foreign currency translation gain (loss), net of tax		69			353			(2,353	)		2,966			976			(1,420	)		(1,339	)		(2,422	)
Comprehensive income	$	2,956		$	581		$	7,291		$	2,736		$	6,525		$	2,702		$	10,534		$	4,335

Net income (loss) per share:
Net income per share:
Common shares - Basic	$	0.22		$	0.02		$	0.73		$	(0.02	)	$	0.40		$	0.31		$	0.87		$	0.52
Class B common shares - Basic		0.19			0.02			0.66			(0.02	)		0.36			0.28			0.78			0.46
Common shares - Diluted		0.21			0.02			0.71			(0.02	)		0.39			0.30			0.83			0.50
Class B common shares - Diluted		0.19			0.02			0.64			(0.02	)		0.35			0.27			0.75			0.45

Weighted average number of shares:
Common shares – Basic		11,497			11,111			11,320			11,097			11,918			11,270			11,816			11,232
Class B common shares – Basic		2,074			2,097			2,089			2,097			2,053			2,097			2,053			2,097
Common shares – Diluted		12,027			11,183			11,724			11,097			12,535			11,697			12,442			11,568
Class B common shares – Diluted		2,074			2,097			2,089			2,097			2,053			2,097			2,053			2,097

Dividends per share:
Common share	$	0.060		$	0.060		$	0.180		$	0.180		$	0.060		$	0.060		$	0.120		$	0.120
Class B common share		0.054			0.054			0.162			0.162			0.054			0.054			0.108			0.108


	Three Months Ended						Nine Months Ended						Three Months Ended						Six Months Ended
	February 26, 2022			February 27, 2021			February 26, 2022			February 27, 2021			November 26, 2022			November 27, 2021			November 26, 2022			November 27, 2021
Operating activities:
Net income (loss)	$	2,887		$	228		$	9,644		$	(230	)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:
Net income													$	5,549		$	4,122		$	11,873		$	6,757
Adjustments to reconcile net income to cash (used in) provided by operating activities:
Depreciation and amortization		872			849			2,560			2,595			893			859			1,776			1,688
Inventory provisions		88			265			228			717			124			57			195			140
Share-based compensation expense		142			150			514			529			213			153			524			372
Loss (gain) on disposal of assets		—			(6	)		2			(6	)
(Gain) loss on disposal of assets														(25	)		2			(25	)		2
Deferred income taxes		26			3			38			(50	)		27			(23	)		28			12
Change in assets and liabilities:
Accounts receivable		(4,209	)		(837	)		(7,355	)		(1,004	)		(2,009	)		1,862			(5,505	)		(3,146	)
Inventories		(3,113	)		133			(12,295	)		(875	)		(7,658	)		(4,225	)		(18,126	)		(9,182	)
Prepaid expenses and other assets		(2	)		428			(1,058	)		156			774			(994	)		(425	)		(1,056	)
Accounts payable		1,902			496			4,204			(2,027	)		(699	)		1,695			796			2,302
Accrued liabilities		563			873			2,075			4,285			(1,062	)		1,032			1,147			1,512
Other		(370	)		216			(13	)		(222	)		(49	)		91			589			357
Net cash (used in) provided by operating activities		(1,214	)		2,798			(1,456	)		3,868			(3,922	)		4,631			(7,153	)		(242	)
Investing activities:
Capital expenditures		(554	)		(555	)		(2,161	)		(1,835	)		(1,301	)		(770	)		(2,743	)		(1,607	)
Proceeds from maturity of investments		—			—			—			16,000
Purchases of investments		—			—			—			(9,000	)
Net cash (used in) provided by investing activities		(554	)		(555	)		(2,161	)		5,165
Proceeds from sale of assets														193			—			193			—
Net cash used in investing activities														(1,108	)		(770	)		(2,550	)		(1,607	)
Financing activities:
Proceeds from issuance of common stock		1,906			—			2,630			—			1,517			672			2,902			724
Cash dividends paid		(806	)		(780	)		(2,384	)		(2,340	)		(831	)		(792	)		(1,650	)		(1,578	)
Payment of financing lease principal		(45	)		(45	)		(136	)		(136	)
Other														—			(46	)		(69	)		(91	)
Net cash provided by (used in) financing activities		1,055			(825	)		110			(2,476	)		686			(166	)		1,183			(945	)
Effect of exchange rate changes on cash and cash equivalents		195			(34	)		(662	)		1,315			(183	)		(448	)		(869	)		(857	)
(Decrease) increase in cash and cash equivalents		(518	)		1,384			(4,169	)		7,872			(4,527	)		3,247			(9,389	)		(3,651	)
Cash and cash equivalents at beginning of period		39,665			37,023			43,316			30,535			30,633			36,418			35,495			43,316
Cash and cash equivalents at end of period	$	39,147		$	38,407		$	39,147		$	38,407		$	26,106		$	39,665		$	26,106		$	39,665

	Common		Class B Common			Par Value		Additional Paid In Capital			Retained Earnings			Accumulated Other Comprehensive Income			Total
Balance May 29, 2021:		11,160		2,097		$	663	$	62,707		$	53,297		$	4,893		$	121,560
																				Common		Class B Common			Par Value		Additional Paid In Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Total
Balance May 28, 2022:																					11,649		2,053		$	685	$	66,331		$	68,031		$	800		$	135,847
Comprehensive income:
Net income		—		—			—		—			9,644			—			9,644			—		—			—		—			11,873			—			11,873
Foreign currency translation		—		—			—		—						(2,353	)		(2,353	)		—		—			—		—			—			(1,339	)		(1,339	)
Share-based compensation:
Restricted stock		—		—			—		339			—			—			339			—		—			—		262			—			—			262
Stock options		—		—			—		175			—			—			175			—		—			—		262			—			—			262
Common stock:
Options exercised		331		—			16		2,614			—			—			2,630			323		—			17		2,885			—			—			2,902
Restricted stock issuance		73		—			4		(4	)		—			—			—			49		—			2		(71	)		—			—			(69	)
Class B converted to Common		44		(44	)		—		—			—			—			—			1		(1	)		—		—			—			—			—
Dividends paid to:
Common ($0.180 per share)		—		—			—		—			(2,047	)		—			(2,047	)
Class B ($0.162 per share)		—		—			—		—			(337	)		—			(337	)
Balance February 26, 2022		11,608		2,053		$	683	$	65,831		$	60,557		$	2,540		$	129,611
Common ($0.120 per share)																					—		—			—		—			(1,428	)		—			(1,428	)
Class B ($0.108 per share)																					—		—			—		—			(222	)		—			(222	)
Balance November 26, 2022																					12,022		2,052		$	704	$	69,669		$	78,254		$	(539	)	$	148,088

Balance November 27, 2021:		11,338		2,097		$	672	$	63,794		$	58,476		$	2,471		$	125,413
Balance August 27, 2022:																					11,848		2,053		$	695	$	67,948		$	73,536		$	(1,515	)	$	140,664
Comprehensive income:
Net income		—		—			—		—			2,887			—			2,887			—		—			—		—			5,549			—			5,549
Foreign currency translation		—		—			—		—			—			69			69			—		—			—		—			—			976			976
Share-based compensation:
Restricted stock		—		—			—		105			—			—			105			—		—			—		139			—			—			139
Stock options		—		—			—		37			—			—			37			—		—			—		74			—			—			74
Common stock:
Options exercised		226		—			11		1,895			—			—			1,906			173		—			9		1,508			—			—			1,517
Class B converted to Common		44		(44	)		—		—			—			—			—			1		(1	)		—		—			—			—			—
Dividends paid to:
Common ($0.060 per share)		—		—			—		—			(695	)		—			(695	)
Class B ($0.054 per share)		—		—			—		—			(111	)		—			(111	)
Balance February 26, 2022		11,608		2,053		$	683	$	65,831		$	60,557		$	2,540		$	129,611
Common ($0.060 per share)																					—		—			—		—			(719	)		—			(719	)
Class B ($0.054 per share)																					—		—			—		—			(112	)		—			(112	)
Balance November 26, 2022																					12,022		2,052		$	704	$	69,669		$	78,254		$	(539	)	$	148,088

Common

Class B
Common

Par
Value

Additional
Paid In
Capital

Retained
Earnings

Accumulated
Other
Comprehensive
Income

Total

Balance May 30, 2020:

11,038

2,097

$
657

$
61,749

$
54,764

$
1,490

$
118,660

Comprehensive income:

Net loss

—

—

—

—

(230
)

—

(230
)
Foreign currency translation

—

—

—

—

—

2,966

2,966

Share-based compensation:

Restricted stock

—

—

—

371

—

—

371

Stock options

—

—

—

158

—

—

158

Common stock:

Restricted stock issuance

73

—

4

(4
)

—

—

—

Dividends paid to:

Common ($0.180 per share)

—

—

—

—

(2,000
)

—

(2,000
)
Class B ($0.162 per share)

—

—

—

—

(340
)

—

(340
)
Balance February 27, 2021

11,111

2,097

$
661

$
62,274

$
52,194

$
4,456

$
119,585

Balance November 28, 2020:

11,111

2,097

$
661

$
62,124

$
52,746

$
4,103

$
119,634

Comprehensive income:

Net income

—

—

—

—

228

—

228

Foreign currency translation

—

—

—

—

—

353

353

Share-based compensation:

Restricted stock

—

—

—

112

—

—

112

Stock options

—

—

—

38

—

—

38

Dividends paid to:

Common ($0.060 per share)

—

—

—

—

(667
)

—

(667
)
Class B ($0.054 per share)

—

—

—

—

(113
)

—

(113
)
Balance February 27, 2021

11,111

2,097

$
661

$
62,274

$
52,194

$
4,456

$
119,585

3. CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Inventories, net: Our consolidated inventories were stated at the lower of cost and net realizable value, generally using a weighted-average cost method. Our net inventories include approximately $80.2 million of finished goods, $11.2 million of raw materials and $6.0 million of work-in-progress as of November 26, 2022, as compared to approximately $66.6 million of finished goods, $8.0 million of raw materials and $5.8 million of work-in-progress as of May 28, 2022.

At this time, we do not anticipate any material risks or uncertainties related to possible future inventory write-downs. Provisions for obsolete or slow-moving inventories are recorded based upon regular analysis of stock rotation privileges, obsolescence, the exiting of certain markets and assumptions about future demand and market conditions. If future demand changes in the industry, or market conditions differ from management’s estimates, additional provisions may be necessary. Inventory reserves were approximately $6.0 million as of November 26, 2022 and $6.1 million as of May 28, 2022.

Revenue Recognition: Our customers are generally not resellers, but rather businesses that incorporate our products into their processes from which they generate an economic benefit. The goods are also distinct in that each item sold to the customer is clearly identified on both the purchase order and resulting invoice. Each product we sell benefits the customer independently of the other products. Each item on each purchase order from the customer can be used by the customer unrelated to any other products we provide to the customer.

The Company’s revenue includes the following streams:

•

Manufacturing/assembly

•

Distribution

•

Services revenue

Manufacturing/assembly typically includes the products that are manufactured or assembled in our manufacturing facility. These products can either be built to the customer’s prints/designs or are products that we stock in our warehouse to sell to any customer that places an order. The manufacturing business does not include a separate service bundled with the product sold or sold in addition to the product. Our contracts for customized products generally include termination provisions if a customer cancels its order. However, we recognize revenue at a point in time because the termination provisions normally do not require, upon cancelation, the customer to pay fees that are commensurate with the work performed. Each purchase order explicitly states the goods or service that we promise to transfer to the customer. The promises to the customer are limited only to those goods or service. The performance obligation is our promise to deliver both goods that were produced by the Company and resale of goods that we purchase from our suppliers. Our shipping and handling activities for destination shipments are performed prior to the customer obtaining control. As such, they are not a separate promised service. The Company elects to account for shipping and handling as activities to fulfill the promise to transfer the goods. The goods we provide to our customers are distinct in that our customers benefit from the goods we sell them through use in their own processes.

Distribution typically includes products purchased from our suppliers, stocked in our warehouses and then sold to our customers. The distribution business does not include a separate service bundled with the product sold or sold on top of the product. Revenue is recognized when control of the promised goods is transferred to our customers, which is simultaneous with the title transferring to the customer, in an amount that reflects the transaction price consideration that we expect to receive in exchange for those goods. Control refers to the ability of the customer to direct the use of, and obtain substantially all of, the remaining benefits from the goods. Our transaction price consideration is fixed, unless otherwise disclosed below as variable consideration. Generally, our contracts require our customers to pay for goods after we deliver products to them. Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America subject to customary credit checks.

Repair, installation or training activities generate services revenue. The services we provide are relatively short in duration and typically completed in one or two weeks. Therefore, at each reporting date, the amount of unbilled work is insignificant. The services revenue has consistently accounted for less than 5% of the Company’s total revenues and is expected to continue at that level.

We record discounts taken based on historical experience. The policy varies by business unit. The Company allows returns with prior written authorization. We estimate returns based on historical experience. The Company maintains a reserve for returns based on historical trends that covers all contracts and revenue streamsusing the expected value method because we have a large number of contracts with similar characteristics, which is considered variable consideration. The reserve for returns creates a refund liability on our balance sheet as a contra trade accounts receivable as well as an asset in inventory. We value the inventory at cost due to there being minimal or no costs to the Company as we generally require the customer to pay freight and we typically do not have costs associated with activities such as relabeling or repackaging. The reserve is considered immaterial at each balance sheet date. Returns for defective product are typically covered by our suppliers’ warranty, thus, returns for defective product are not factored into our reserve.

Principal versus agent guidance was considered for customized products that are provided by our suppliers versus manufactured by the Company. The Company acts as the principal as we are responsible for satisfying the performance obligation. We have primary responsibility for fulfilling the contract, we have inventory risk prior to delivery to our customer, we establish prices, our consideration is not in the form of a commission and we bear the credit risk. The Company recognizes revenue in the gross amount of consideration.

Contracts with customers

A revenue contract exists once a customer purchase order is received, reviewed and accepted. Each accepted purchase order identifies a distinct good or service as the performance obligation. The goods include standard products purchased from a supplier and stocked on our shelves, customized products purchased from a supplier, products that are customized or have value added to them in house prior to shipping to the customer and manufactured products. Prior to accepting a customer purchase order, we review the credit worthiness of the customer. Purchase orders are deemed to meet the collectability criterion once the customer’s credit is approved. The Company receives advance payments or deposits from our customers before revenue is recognized resulting in contract liabilities. Contract liabilities are included in accrued liabilities in the consolidated balance sheets.

Contract Liabilities: Contract liabilities and revenue recognized were as follows (in thousands):


	May 28, 2022		Additions		Revenue Recognized			November 26, 2022
Contract liabilities (deferred revenue)	$	4,966	$	2,543	$	(3,010	)	$	4,499

See Note 7, Segment Reporting, for a disaggregation of revenue by reportable segment and geographic region, which represents how our chief operating decision maker reviews information internally to evaluate our financial performance and to make resource allocation and other decisions for the Company.

Loss Contingencies: We accrue a liability for loss contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. If we determine that there is at least a reasonable possibility that a loss may have been incurred, we will include a disclosure describing the contingency.

Intangible Assets: Intangible assets are initially recorded at their fair market values determined by quoted market prices in active markets, if available, or recognized valuation models. Intangible assets that have finite useful lives are amortized over their useful lives either on a straight-line basis or over their projected future cash flows and are tested for impairment when events or changes in circumstances occur that indicate possible impairment. Our intangible assets represent the fair value for trade name, customer relationships and non-compete agreements acquired in connection with the acquisitions. Technology represents the fair value acquired in connection with acquisitions and an exclusive license, manufacturing and distribution agreement. Intangible assets subject to amortization were as follows (in thousands):


	November 26, 2022		May 28, 2022
Gross Amounts:
Trade Name	$	659	$	659
Customer Relationships(1)		3,383		3,393
Non-compete Agreements		177		177
Technology		380		230
Total Gross Amounts	$	4,599	$	4,459

Accumulated Amortization:
Trade Name	$	659	$	659
Customer Relationships		1,555		1,453
Non-compete Agreements		177		177
Technology		183		160
Total Accumulated Amortization	$	2,574	$	2,449

Net Intangible Assets	$	2,025	$	2,010

(1)

Change from prior periods reflect impact of foreign currency translation.

The amortization expense associated with the intangible assets subject to amortization for the next five years is presented in the following table (in thousands):


Fiscal Year	Amortization Expense
Remaining 2023	$	134
2024		252
2025		240
2026		205
2027		194
Thereafter		1,000
Total amortization	$	2,025

The weighted average number of years of amortization expense remaining is 11.5 years.

Income Taxes: We recognize deferred tax assets and liabilities based on the differences between financial statement carrying amounts and the tax bases of assets and liabilities. We regularly review our deferred tax assets for recoverability and determine the need for a valuation allowance based on a number of factors, including both positive and negative evidence. These factors include historical taxable income or loss, projected future taxable income or loss, the expected timing of the reversals of existing temporary differences and the implementation of tax planning strategies. In circumstances where we, or any of our affiliates, have incurred three years of cumulative losses which constitute significant negative evidence, positive evidence of equal or greater significance is needed to overcome the negative evidence before a tax benefit is recognized for deductible temporary differences and loss carryforwards.

Accrued Liabilities: Accrued liabilities consisted of the following (in thousands):


	November 26, 2022		May 28, 2022
Compensation and payroll taxes	$	4,484	$	5,519
Accrued severance		516		678
Professional fees		738		470
Deferred revenue		4,499		4,966
Other accrued expenses		6,837		4,477
Accrued Liabilities	$	17,074	$	16,110

Warranties:We offer warranties for the limited number of specific products we manufacture.

We estimate the cost to perform under the warranty obligation and recognize this estimated cost at the time of the related product sale. We record expense related to our warranty obligations as cost of sales in our consolidated statements of comprehensive income. Each quarter, we assess actual warranty costs incurred on a product-by-product basis and compare the warranty costs to our estimated warranty obligation. With respect to new products, estimates are based generally on knowledge of the products and warranty experience.

Warranty reserves are established for costs that are expected to be incurred after the sale and delivery of products under warranty. Warranty reserves are included in accrued liabilities on our consolidated balance sheets. The warranty reserves are determined based on known product failures, historical experience and other available evidence. Warranty reserves were approximately $0.8 million as of November 26, 2022 and $0.7 million as of May 28, 2022.

4. LEASE OBLIGATIONS AND OTHER COMMITMENTS

The Company leases real and personal property in the normal course of business under various operating and financing leases. The Company uses operating leases for facility space and automobiles. Most of the leased facility space is for sales and general office use. Automobile leases are used throughout the Company. Financing leases are used for computer servers.

Several leases include renewal clauses which vary in length and may not include specific rent renewal amounts. The Company will revise the value of the right of use assets and associated lease liabilities when the Company determines it is reasonably certain of renewal.

The gross amounts of assets and liabilities related to both operating and financing leases were as follows (in thousands):


Lease Type	November 26, 2022		May 28, 2022
Operating lease ROU asset	$	2,527	$	3,024
Financing lease ROU asset		—		215
Total lease ROU asset	$	2,527	$	3,239
Operating lease liability current	$	1,015	$	1,109
Operating lease liability non-current	$	1,512	$	1,915

The components of lease costs were as follows (in thousands):


		Three Months Ended
		November 26, 2022		November 27, 2021
Consolidated operating lease expense	Operating expenses	$	411	$	446

Consolidated financing lease amortization	Operating expenses		—		23
Consolidated financing lease interest	Interest expense		—		1
Consolidated financing lease expense			—		24

Net lease cost		$	411	$	470


		Six Months Ended
		November 26, 2022		November 27, 2021
Consolidated operating lease expense	Operating expenses	$	865	$	901

Consolidated financing lease amortization	Operating expenses		—		46
Consolidated financing lease interest	Interest expense		—		3
Consolidated financing lease expense			—		49

Net lease cost		$	865	$	950

The approximate future minimum lease payments under operating leases at November 26, 2022 were as follows (in thousands):


Fiscal Year	Operating Leases
Remaining 2023	$	611
2024		920
2025		643
2026		400
2027		75
Thereafter		16
Total lease payments		2,665
Less imputed interest		138
Net minimum lease payments	$	2,527

The weighted average remaining lease terms and interest rates of leases held by the Company as of November 26, 2022 were as follows:


Lease Type	Weighted Average Remaining Lease Term in Years	Weighted Average Interest Rate
Operating leases	2.9	4.2%

The cash outflows of the leasing activity of the Company as lessee for the six months ending November 26, 2022 and November 27, 2021 were as follows (in thousands):


		Six Months Ended
Cash Flow Source	Classification	November 26, 2022		November 27, 2021
Operating cash flows from operating leases	Operating activities	$	496	$	1,303
Operating cash flows from financing leases	Operating activities		—		88
Finance cash flows from financing leases	Financing activities		—		91

6. CALCULATION OF EARNINGS PER SHARE

We have authorized 17,000,000 shares of common stock and 3,000,000 shares of Class B common stock. The Class B common stock has 10 votes per share and has transferability restrictions; however, Class B common stock may be converted into common stock on a share-for-share basis at any time. With respect to dividends and distributions, shares of common stock and Class B common stock rank equally and have the same rights, except that Class B common stock cash dividends are limited to 90% of the amount of common stock cash dividends.

Our Class B common stock is considered a participating security requiring the use of the two-class method for the computation of basic and diluted earnings per share. The two-class computation method for each period reflects the cash dividends paid per share for each class of stock, plus the amount of allocated undistributed earnings per share computed using the participation percentage which reflects the dividend rights of each class of stock. Basic and diluted earnings per share were computed using the two-class method. The shares of Class B common stock are considered to be participating convertible securities since the shares of Class B common stock are convertible on a share-for-share basis into shares of common stock and may participate in dividends with common stock according to a predetermined formula which is 90% of the amount of common stock cash dividends.

The earnings per share (“EPS”) presented in our unaudited consolidated statements of comprehensive income were based on the following amounts (in thousands, except per share amounts):


	Three Months Ended
	November 26, 2022				November 27, 2021
	Basic		Diluted		Basic		Diluted
Numerator for Basic and Diluted EPS:
Net income	$	5,549	$	5,549	$	4,122	$	4,122
Less dividends:
Common stock		719		719		679		679
Class B common stock		112		112		113		113
Undistributed earnings	$	4,718	$	4,718	$	3,330	$	3,330

Common stock undistributed earnings	$	4,085	$	4,112	$	2,852	$	2,867
Class B common stock undistributed earnings		633		606		478		463
Total undistributed earnings	$	4,718	$	4,718	$	3,330	$	3,330

Denominator for Basic and Diluted EPS:
Common stock weighted average shares		11,918		11,918		11,270		11,270
Effect of dilutive securities
Dilutive stock options				617				427
Denominator for diluted EPS adjusted for weighted average shares and assumed conversion				12,535				11,697
Class B common stock weighted average shares and shares under if-converted method for diluted EPS		2,053		2,053		2,097		2,097

Net income per share:
Common stock	$	0.40	$	0.39	$	0.31	$	0.30
Class B common stock	$	0.36	$	0.35	$	0.28	$	0.27

Note: There were no common stock options that were antidilutive in the second quarter of fiscal 2023 and fiscal 2022.


	Six Months Ended
	November 26, 2022				November 27, 2021
	Basic		Diluted		Basic		Diluted
Numerator for Basic and Diluted EPS:
Net income	$	11,873	$	11,873	$	6,757	$	6,757
Less dividends:
Common stock		1,428		1,428		1,352		1,352
Class B common stock		222		222		226		226
Undistributed earnings	$	10,223	$	10,223	$	5,179	$	5,179

Common stock undistributed earnings	$	8,841	$	8,901	$	4,434	$	4,453
Class B common stock undistributed earnings		1,382		1,322		745		726
Total undistributed earnings	$	10,223	$	10,223	$	5,179	$	5,179

Denominator for Basic and Diluted EPS:
Common stock weighted average shares		11,816		11,816		11,232		11,232
Effect of dilutive securities
Dilutive stock options				626				336
Denominator for diluted EPS adjusted for weighted average shares and assumed conversion				12,442				11,568
Class B common stock weighted average shares and shares under if-converted method for diluted EPS		2,053		2,053		2,097		2,097

Net income per share:
Common stock	$	0.87	$	0.83	$	0.52	$	0.50
Class B common stock	$	0.78	$	0.75	$	0.46	$	0.45

7. SEGMENT REPORTING

The Company began reporting the results for its new Green Energy Solutions ("GES") segment in the first quarter of fiscal 2023 due to its focus on the power applications that support the green energy market. The GES segment has been carved out of our existing Power and Microwave Technologies (“PMT”) segment. Accordingly, the Company is reporting its financial performance based on four operating and reportable segments. The results for fiscal 2022 presented herein were adjusted to reflect the presentation of the new GES segment separately from the PMT segment.

The Company's four operating and reportable segments are defined as follows:

Power and Microwave Technologies combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies. As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. PMT’s focus is on products for power, RF and microwave applications for customers in 5G, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.

Green Energy Solutions combines our key technology partners and engineered solutions capabilities to design and manufacture key products for the fast-growing energy storage market and power management applications. As a designer, manufacturer, technology partner and authorized distributor, GES’s strategy is to provide specialized technical expertise and engineered solutions using our core design engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. GES’s focus is on products for numerous green energy applications such as wind, solar, hydrogen and Electric Vehicles, and other power management applications that support green solutions such as synthetic diamond manufacturing.

Canvys provides customized display solutions serving the corporate enterprise, financial, healthcare, industrial and medical original equipment manufacturers markets. Our engineers design, manufacture, source and support a full spectrum of solutions to match the needs of our customers. We offer long term availability and proven custom display solutions that include touch screens, protective panels, custom enclosures, All-In-One computers, specialized cabinet finishes and application specific software packages and certification services. We partner with both private label manufacturing companies and leading branded hardware vendors to offer the highest quality display and touch solutions and customized computing platforms.

Healthcare manufactures, repairs, refurbishes and distributes high value replacement parts and equipment for the healthcare market including hospitals, medical centers, asset management companies, independent service organizations and multi-vendor service providers. Products include diagnostic imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI coils, cold heads and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; pre-owned CT systems; and additional replacement solutions currently under development for the diagnostic imaging service market. Through a combination of newly developed products and partnerships, service offerings and training programs, we believe we can help our customers improve efficiency while lowering the cost of healthcare delivery.

The CEO, who is the chief operating decision maker, evaluates performance and allocates resources primarily based on the gross profit of each segment.

Operating results by segment are summarized in the following table (in thousands):


	Three Months Ended				Six Months Ended
	November 26, 2022		November 27, 2021		November 26, 2022		November 27, 2021
PMT
Net Sales	$	40,585	$	36,826	$	85,939	$	77,261
Gross Profit		14,011		12,399		29,546		24,586
GES
Net Sales		12,293		4,911		20,804		7,485
Gross Profit		4,162		1,587		7,184		2,331
Canvys
Net Sales		10,079		9,150		20,492		17,591
Gross Profit		2,995		2,912		6,261		5,730
Healthcare
Net Sales		2,948		3,092		6,227		5,346
Gross Profit		683		759		1,887		1,307

Geographic net sales information is primarily grouped by customer destination into five areas: North America; Asia/Pacific; Europe; Latin America; and Other.

Net sales and gross profit by geographic region are summarized in the following table (in thousands):


	Three Months Ended						Six Months Ended
	November 26, 2022			November 27, 2021			November 26, 2022			November 27, 2021
Net Sales
North America	$	31,577		$	24,440		$	63,405		$	44,968
Asia/Pacific		15,306			11,699			32,860			24,945
Europe		16,574			15,114			31,930			32,164
Latin America		2,461			2,721			5,306			5,596
Other (1)		(13	)		5			(39	)		10
Total	$	65,905		$	53,979		$	133,462		$	107,683
Gross Profit
North America	$	12,184		$	8,658		$	25,463		$	16,038
Asia/Pacific		4,791			3,919			10,321			8,065
Europe		4,943			4,834			9,285			9,623
Latin America		883			1,000			1,902			2,081
Other (1)		(950	)		(754	)		(2,093	)		(1,853	)
Total	$	21,851		$	17,657		$	44,878		$	33,954

(1)

Other includes primarily net sales not allocated to a specific geographical region, unabsorbed value-add costs and other unallocated expenses.

We sell our products to customers in diversified industries and perform periodic credit evaluations of our customers’ financial condition. Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America. Estimates of credit losses are recorded in the financial statements based on monthly reviews of outstanding accounts.

Certain statements in this report may constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. The terms “may”, “should”, “could”, “anticipate”, “believe”, “continues”, “estimate”, “expect”, “intend”, “objective”, “plan”, “potential”, “project” and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These statements are based on management’s current expectations, intentions or beliefs and are subject to a number of factors, assumptions and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause or contribute to such differences or that might otherwise impact the business include; economic, labor and political systems and conditions; global business disruption caused by the Russia invasion in Ukraine and related sanctions: currency exchange fluctuations; and the ability of the Company to manage its growth and the risk factors set forth in our Annual Report on Form 10-K filed with the SEC on August 1, 2022. We undertake no obligation to update any such factor or to publicly announce the results of any revisions to any forward-looking statements contained herein whether as a result of new information, future events or otherwise.

In addition, while we do, from time to time, communicate with securities analysts, it is against our policy to disclose to them any material non-public information or other confidential commercial information. Accordingly, stockholders should not assume that we agree with any statement or report issued by any analyst irrespective of the content of the statement or report. Thus, to the extent that reports issued by securities analysts contain any projections, forecasts or opinions, such reports are not our responsibility.

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to assist the reader in better understanding our business, results of operations, financial condition, changes in financial condition and significant developments. MD&A is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes appearing elsewhere in this filing. This section is organized as follows:

Richardson Electronics, Ltd. is a leading global manufacturer of engineered solutions, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components; high-value replacement parts, tubes, and service training for diagnostic imaging equipment; and customized display solutions. More than 60% of our products are manufactured in LaFox, Illinois, Marlborough, Massachusetts, or Donaueschingen, Germany, or by one of our manufacturing partners throughout the world. All our partners manufacture to our strict specifications and per our supplier code of conduct. We serve customers in the alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The Company’s strategy is to provide specialized technical expertise and “engineered solutions” based on our core engineering and manufacturing capabilities. The Company provides solutions and adds value through design-in support, systems integration, prototype design and manufacturing, testing, logistics, and aftermarket technical service and repair through its global infrastructure.

Our products include electron tubes and related components, microwave generators, subsystems used in semiconductor manufacturing and visual technology solutions. These products are used to control, switch or amplify electrical power signals, or are used as display devices in a variety of industrial, commercial, medical and communication applications.

Power and Microwave Technologies Group (“PMT”) combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies. As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. PMT’s focus is on products for power, RF and microwave applications for customers in 5G, alternative energy, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.

~~We currently have operations in the following major geographic regions: North America, Asia/Pacific, Europe and Latin America.~~

The accompanying unaudited consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and notes required by GAAP for complete financial statements.

Our fiscal quarter ends on the Saturday nearest the end of the quarter-ending month. The third quarter of fiscal 2022 and fiscal 2021 both contained 13 weeks. The first nine months of fiscal 2022 and fiscal 2021 both contained 39 weeks.

In the opinion of management, all adjustments, which are of a normal and recurring nature, necessary for a fair presentation of the results of interim periods have been made. All inter-company transactions and balances have been eliminated. The unaudited consolidated financial statements presented herein include the accounts of our wholly owned subsidiaries. Certain information and

note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results of our operations for the three months and nine months ended February 26, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending May 28, 2022.

~~The financial information contained in this report should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended May 29, 2021, which was filed on August 2, 2021.~~

~~Inventories, net:~~ Our consolidated inventories were stated at the lower of cost and net realizable value, generally using a weighted-average cost method. Our net inventories include approximately $62.1 million of finished goods, $7.0 million of raw materials and $4.6 million of work-in-progress as of February 26, 2022, as compared to approximately $57.0 million of finished goods, $3.9 million of raw materials and $2.6 million of work-in-progress as of May 29, 2021.

At this time, we do not anticipate any material risks or uncertainties related to possible future inventory write-downs. Provisions for obsolete or slow-moving inventories are recorded based upon regular analysis of stock rotation privileges, obsolescence, the exiting of certain markets and assumptions about future demand and market conditions. If future demand changes in the industry, or market conditions differ from management’s estimates, additional provisions may be necessary. Inventory reserves were approximately $5.9 million as of February 26, 2022 and $5.9 million as of May 29, 2021.

~~Revenue Recognition:~~ The Company’s revenue streams include distribution, manufacturing and service revenue. The distribution business does not include a separate service bundled with the product sold or sold on top of the product. Distribution typically includes products purchased from our suppliers, stocked in our warehouses and then sold to our customers. Revenue is recognized when control of the promised goods is transferred to our customers, which is simultaneous with the title transferring to the customer, in an amount that reflects the transaction price consideration that we expect to receive in exchange for those goods. Control refers to the ability of the customer to direct the use of, and obtain substantially all of, the remaining benefits from the goods. Our transaction price consideration is fixed, unless otherwise disclosed below as variable consideration. Generally, our contracts require our customers to pay for goods after we deliver products to them. Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America subject to customary credit checks.

The Company also sells products that are manufactured or assembled in our manufacturing facility. These products can either be built to the customer’s prints/designs or are products that we stock in our warehouse to sell to any customer that places an order. The manufacturing business does not include a separate service bundled with the product sold or sold in addition to the product.

The Company recognizes services revenue when the repair, installation or training is performed. The services we provide are relatively short in duration and typically completed in one or two weeks. Therefore, at each reporting date, the amount of unbilled work is insignificant. The services revenue has consistently accounted for less than 5% of the Company’s total revenues and is expected to continue at that level.

We also record discounts taken and estimate returns based on historical experience. Our products are often manufactured to meet the specific design needs of our customers’ applications. Our engineers work closely with customers to ensure that our products will meet their needs. Our customers are under no obligation to compensate us for designing the products we sell.

A revenue contract exists once a customer purchase order is received, reviewed and accepted. Prior to accepting a customer purchase order, we review the credit worthiness of the customer. Purchase orders are deemed to meet the collectability criterion once the customer’s credit is approved.

~~Contract Liabilities:~~ ~~Contract liabilities and revenue recognized were as follows (in thousands~~):

The Company receives advance payments or deposits from our customers before revenue is recognized resulting in contract liabilities. Contract liabilities are included in accrued liabilities in the consolidated balance sheets.

~~Performance obligations and satisfaction of performance obligation in the contract~~

Each accepted purchase order identifies a distinct good or service as the performance obligation. The goods are generally standard products we purchased from a supplier and stocked on our shelves. They can also be customized products purchased from a supplier or products that are customized or have value added to them in house prior to shipping to the customer. Our contracts for customized products generally include termination provisions if a customer cancels its order. However, we recognize revenue at a point in time because the termination provisions do not require, upon cancelation, the customer to pay fees that are commensurate with the work performed. Each purchase order explicitly states the goods or service that we promise to transfer to the customer. The promises to the customer are limited only to those goods or service. The performance obligation is our promise to deliver both goods

that were produced by the Company and resale of goods that we purchase from our suppliers. Our shipping and handling activities for destination shipments are performed prior to the customer obtaining control. As such, they are not a separate promised service. For shipping point, the Company is making the election under ASC 606-10-25-18B to account for shipping and handling as activities to fulfill the promise to transfer the goods. The goods we provide to our customers are distinct in that our customers benefit from the goods we sell them through use in their own processes. Our customers are generally not resellers, but rather businesses that incorporate our products into their processes from which they generate an economic benefit. The goods are also distinct in that each item sold to the customer is clearly identified on both the purchase order and resulting invoice. Each product we sell benefits the customer independently of the other products. Each item on each purchase order from the customer can be used by the customer unrelated to any other products we provide to the customer.

~~The transaction price for each product is the amount invoiced to the customer.~~ ~~Each product on a purchase order is a separate performance obligation with an observable standalone selling price.~~ ~~The transaction price is a fixed price per unit, except for the variable consideration. The Company elects to exclude sales tax from the transaction price.~~

We recognize revenue at a point in time when title transfers to the customer, at the shipping point for FOB shipping contracts and at the customer’s delivery location for FOB destination contracts. We believe that the transfer of title best represents when the customer obtains control of the goods. Prior to that date, we do not have right to payment, and the significant risks and rewards remain with us. The significant risks and rewards of ownership of the inventory transfer simultaneously with the transfer of title. The customer’s acceptance of the goods is based on objective measurements, not subjective.

Our return policy is available to customers in our terms and conditions found on our website www.rell.com. The policy varies by business unit. The Company allows returns with prior written authorization and we allow returns within ten days of shipment for replacement parts.

~~The Company maintains a reserve for returns based on historical trends that covers all contracts and revenue streams~~using the expected value method because we have a large number of contracts with similar characteristics, which is considered variable consideration. The reserve for returns creates a refund liability on our balance sheet as a contra Trade Accounts Receivable as well as an asset in inventory. We value the inventory at cost due to there being minimal or no costs to the Company as we generally require the customer to pay freight and we typically do not have costs associated with activities such as relabeling or repackaging.

The reserve is considered immaterial at each balance sheet date for further consideration. Returns for defective product are typically covered by our suppliers’ warranty, thus, returns for defective product are not factored into our reserve.

~~We offer warranties for the limited number of specific products we manufacture.~~ ~~For further information regarding the impact of warranties see the~~ ~~Warranties~~ ~~discussion elsewhere in Note 3.~~

~~See Note 7,~~ ~~Segment Reporting,~~ for a disaggregation of revenue by reportable segment and geographic region, which represents how our chief operating decision maker reviews information internally to evaluate our financial performance and to make resource allocation and other decisions for the Company.

~~Loss Contingencies:~~ We accrue a liability for loss contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. If we determine that there is at least a reasonable possibility that a loss may have been incurred, we will include a disclosure describing the contingency.

~~Intangible Assets:~~ Intangible assets are initially recorded at their fair market values determined by quoted market prices in active markets, if available, or recognized valuation models. Intangible assets that have finite useful lives are amortized over their useful lives either on a straight-line basis or over their projected future cash flows and are tested for impairment when events or changes in circumstances occur that indicate possible impairment. Our intangible assets represent the fair value for trade name, customer relationships, non-compete agreements and technology acquired in connection with the acquisitions. Intangible assets subject to amortization were as follows ~~(in thousands)~~:

~~The amortization expense associated with the intangible assets subject to amortization for the next five years is presented in the following table~~ ~~(in thousands)~~:

~~The weighted average number of years of amortization expense remaining is 12.2 years.~~

~~Income Taxes:~~ We recognize deferred tax assets and liabilities based on the differences between financial statement carrying amounts and the tax bases of assets and liabilities. We regularly review our deferred tax assets for recoverability and determine the need for a valuation allowance based on a number of factors, including both positive and negative evidence. These factors include historical taxable income or loss, projected future taxable income or loss, the expected timing of the reversals of existing temporary differences and the implementation of tax planning strategies. In circumstances where we, or any of our affiliates, have incurred three years of cumulative losses which constitute significant negative evidence, positive evidence of equal or greater significance is needed to overcome the negative evidence before a tax benefit is recognized for deductible temporary differences and loss carryforwards.

~~Accrued Liabilities:~~ ~~Accrued liabilities consisted of the following (in thousands):~~

~~Warranties:We offer warranties for the limited number of specific products we manufacture.~~ ~~Our warranty terms generally range from one to three years.~~

Warranty reserves are established for costs that are expected to be incurred after the sale and delivery of products under warranty. Warranty reserves are included in accrued liabilities on our consolidated balance sheets. The warranty reserves are determined based on known product failures, historical experience and other available evidence. Warranty reserves were approximately $0.7 million as of February 26, 2022 and $0.5 million as of May 29, 2021.

The Company leases real and personal property in the normal course of business under various operating leases and financing leases. The Company has two types of operating leases: leases for facility space and leases for automobiles. Most of the leased facility space is for sales and general office use. Automobile leases are used throughout the Company. The financing lease is for our computer servers.

~~The gross amounts of assets and liabilities related to both operating and financing leases were as follows~~ ~~(in thousands)~~:

~~The approximate future minimum lease payments under operating and financing leases at February 26, 2022 were as follows~~ ~~(in thousands)~~:

~~The weighted average remaining lease terms and interest rates of leases held by the Company as of February 26, 2022 were as follows:~~

~~The cash outflows of the leasing activity of the Company as lessee for the nine months ending February 26, 2022 and February 27, 2021 were as follows~~ ~~(in thousands)~~:

We recorded an income tax provision of $1.3 million and $0.2 million for the first nine months of fiscal 2022 and the first nine months of fiscal 2021, respectively. The increase in the tax provision from fiscal 2021 reflects higher foreign taxes, geographical distribution of income (loss) and state income tax provision due to temporary suspension of net operating loss utilization in Illinois and California.

In the normal course of business, we are subject to examination by taxing authorities throughout the world. Generally, years prior to fiscal 2015 are closed for examination under the statute of limitation for U.S. federal, U.S. state and local or non-U.S. tax jurisdictions. We are currently under examination in Thailand (fiscal 2008 through 2011) and Germany (fiscal 2015 through 2018). Our primary foreign tax jurisdictions are Germany and the Netherlands. We have tax years open in Germany beginning in fiscal 2015 and the Netherlands beginning in fiscal 2018.

We have historically determined that certain undistributed earnings of our foreign subsidiaries, to the extent of cash available, will be repatriated to the U.S. The deferred tax liability on the outside basis difference is now primarily withholding tax on future dividend distributions. We have provided a deferred tax liability of less than $0.1 million as of both February 26, 2022 and as of May 29, 2021.

As of February 26, 2022 and as of May 29, 2021, our worldwide liability for uncertain tax positions related to continuing operations was $0.1 million, excluding interest and penalties. We record penalties and interest related to uncertain tax positions in the income tax expense line item within the consolidated statements of comprehensive income.

The valuation allowance against the net deferred tax assets that will more likely than not be realized was $9.6 million as of February 26, 2022. The valuation allowance against the net deferred tax assets was $12.2 million as of May 29, 2021 and the Company is utilizing prior losses in the first three quarters of fiscal 2022 against its income. A full valuation allowance on the U.S. and state deferred tax assets will be maintained until sufficient positive evidence related to sources of future taxable income exists to support a reversal of the valuation allowance. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are increased, or if objective negative evidence in the form of cumulative losses is no longer present and additional weight may be given to subjective evidence such as our projections for growth.

~~The earnings per share (“EPS”) presented in our unaudited consolidated statements of comprehensive income were based on the following amounts (in thousands, except per share amounts~~):

Three Months Ended

February 26, 2022

February 27, 2021

Basic

Diluted

Basic

Diluted

Numerator for Basic and Diluted EPS:

Net income

$
2,887

$
2,887

$
228

$
228

Less dividends:

Common stock

695

695

667

667

Class B common stock

111

111

113

113

Undistributed earnings (loss)

$
2,081

$
2,081

$
(552
)

$
(552
)

Common stock undistributed earnings (loss)

$
1,790

$
1,801

$
(472
)

$
(472
)
Class B common stock undistributed earnings (loss)

291

280

(80
)

(80
)
Total undistributed earnings (loss)

$
2,081

$
2,081

$
(552
)

$
(552
)

Denominator for Basic and Diluted EPS:

Common stock weighted average shares

11,497

11,497

11,111

11,111

Effect of dilutive securities

Dilutive stock options

530

72

Denominator for diluted EPS adjusted for weighted average shares and assumed conversion

12,027

11,183

Class B commons stock weighted average shares and shares under if-converted method for diluted EPS

2,074

2,074

2,097

2,097

Net income per share:

Common stock

$
0.22

$
0.21

$
0.02

$
0.02

Class B common stock

$
0.19

$
0.19

$
0.02

$
0.02

~~Note: There were 0 common stock options that were antidilutive in the third quarter of fiscal 2022 and fiscal 2021.~~

Nine Months Ended

February 26, 2022

February 27, 2021

Basic

Diluted

Basic

Diluted

Numerator for Basic and Diluted EPS:

Net income (loss)

$
9,644

$
9,644

$
(230
)

$
(230
)
Less dividends:

Common stock

2,047

2,047

2,000

2,000

Class B common stock

337

337

340

340

Undistributed earnings (loss)

$
7,260

$
7,260

$
(2,570
)

$
(2,570
)

Common stock undistributed earnings (loss)

$
6,226

$
6,257

$
(2,196
)

$
(2,196
)
Class B common stock undistributed earnings (loss)

1,034

1,003

(374
)

(374
)
Total undistributed earnings (loss)

$
7,260

$
7,260

$
(2,570
)

$
(2,570
)

Denominator for Basic and Diluted EPS:

Common stock weighted average shares

11,320

11,320

11,097

11,097

Effect of dilutive securities

Dilutive stock options

404

—

Denominator for diluted EPS adjusted for weighted average shares and assumed conversion

11,724

11,097

Class B commons stock weighted average shares and shares under if-converted method for diluted EPS

2,089

2,089

2,097

2,097

Net income (loss) per share:

Common stock

$
0.73

$
0.71

$
(0.02
)

$
(0.02
)
Class B common stock

$
0.66

$
0.64

$
(0.02
)

$
(0.02
)

Note: There were 0 common stock options that were antidilutive in the first nine months of fiscal 2022. Common stock options that were anti-dilutive and not included in the diluted earnings per common share for the first nine months of fiscal 2021 were 1,300.

PMT combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies. As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. PMT’s focus is on products for power, RF and microwave applications for customers in 5G, alternative energy, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.

~~The CEO, who is the chief operating decision maker, evaluates performance and allocates resources primarily based on the gross profit of each segment.~~

~~Operating results by segment are summarized in the following table (in thousands~~):

~~Geographic net sales information is primarily grouped by customer destination into five areas: North America; Asia/Pacific; Europe; Latin America; and Other.~~

~~Net sales and gross profit by geographic region are summarized in the following table (in thousands~~):

~~In March 2020, the World Health Organization classified the outbreak of COVID-19 as a pandemic.~~ ~~Thereafter, most U.S. states imposed “shelter in place” or similar directives on their populations to stem the spread of COVID-19 and similar restrictive~~

~~measures were taken by governments across the world. Throughout the duration of such restrictions, the Company~~ was considered a critical supplier of products to healthcare and critical infrastructure businesses and, accordingly, the Company continued our manufacturing and distribution operations as an “essential business” throughout the implementation of various restrictions on operations in our fiscal 2021 and beyond. Our top priority was ensuring the health and safety of our employees and, accordingly, we undertook measures such as limiting the number of people in any one of our facilities by requiring only employees who could not perform their work remotely to physically work in a Company US-based facility. ~~The Company advised all other employees that could perform their job functions remotely to do so. As such, the Company’s operations have remained operational during the pandemic.~~

The impact of the COVID-19 outbreak and its effects continue to evolve. As such, the full magnitude that the pandemic, its effects, and the steps taken to prevent and/or mitigate its spread or otherwise address its impact, will have on the Company’s financial condition, liquidity and future results of operations is uncertain. The extent of the impact of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the duration and spread of the pandemic, the extent, speed and effectiveness of worldwide containment and vaccination effort, any subsequent wave or waves of outbreaks, and the impact of these and other factors on our employees, customers and suppliers. Our ability to meet customer demands for products may be impaired or, similarly, our customers may experience adverse business consequences due to COVID-19 and its effects. Reduced demand for products or impaired ability to meet customer demand (including disruptions at our transportation service providers or vendors or otherwise in our supply chain) could have a material adverse effect on our business, operations and financial performance. While we had some COVID-19 related component delays impacting new product development schedules, we did not experience a major interruption in our supply chain. Management continues to monitor the global situation on its financial condition, liquidity, operations, suppliers, industry and workforce. Given the ever-evolving nature of the pandemic and the continued global responses to curb its spread, the Company is not presently able to fully estimate the effects of COVID-19 on its results of operations, financial condition or liquidity for fiscal year 2022.

On March 27, 2020, Congress enacted the Coronavirus Aid, Relief and Economic Security (“CARES”) Act to provide certain relief as a result of the COVID-19 outbreak. The CARES Act included provisions relating to refundable payroll tax credits, deferral of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, increased limitations on qualified charitable contributions and technical corrections to tax depreciation methods for qualified, improvement property. As of February 26, 2022, the Company deferred $0.5 million of employer-side social security tax payments.~~The Company has estimated and recorded the overall effects of the CARES Act and does not anticipate a material change.~~

~~Investments are measured at fair value. The Company had 0 investments as of February 26, 2022 and May 29, 2021.~~

On June 15, 2015, the Company entered into a lease agreement for the IMES facility with LDL, LLC. That lease agreement was extended for five years in fiscal 2021. The Company shall be entitled to extend the term of the lease for a period of an additional five years by notifying the landlord in writing of its intention to do so within six months of the expiration of the term. The Executive Vice President of IMES, Lee A. McIntyre III (former owner of IMES), has an ownership interest in LDL, LLC. The lease agreement provides for monthly payments over five years with total future minimum lease payments of $0.5 million. Rental expense related to this lease amounted to $0.1 million for the nine months ended February 26, 2022 and February 27, 2021.

Certain statements in this report may constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. The terms “may,” “should,” “could,” “anticipate,” “believe,” “continues,” “estimate,” “expect,” “intend,” “objective,” “plan,” “potential,” “project” and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These statements are based on management’s current expectations, intentions or beliefs and are subject to a number of factors, assumptions and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause or contribute to such differences or that might otherwise impact the business include; economic, labor and political systems and conditions; global business disruption caused by the Russia invasion in Ukraine and related sanctions: currency exchange fluctuations; and the ability of the Company to manage its growth and the risk factors set forth in our Annual Report on Form 10-K filed on August 2, 2021 We undertake no obligation to update any such factor or to publicly announce the results of any revisions to any forward-looking statements contained herein whether as a result of new information, future events or otherwise.

Some of the Company's products are manufactured in China and are imported into the United States. The Office of the United States Trade Representative ("USTR") instituted additional 10% to 25% tariffs on the importation of a number of products into the United States from China effective July 6, 2018, with additional products added August 23, 2018 and September 24, 2018. These additional tariffs are a response to what the USTR considers to be certain unfair trade practices by China. A number of the Company's products manufactured in China are now subject to these additional duties of 25% when imported into the United States.

Management continues to work with its suppliers as well as its customers to mitigate the impact of the tariffs on our customers’ markets. However, if the Company is unable to successfully pass through the additional cost of these tariffs, or if the higher prices reduce demand for the Company's products, it will have a negative effect on the Company's sales and gross margins.

~~We have three~~The Company's four operating and reportable segments ~~which we define~~are defined as follows:

Power and Microwave Technologies ~~Group (“PMT”)~~ combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies. As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. PMT’s focus is on products for power, RF and microwave applications for customers in 5G, ~~alternative energy,~~ aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.

Canvys provides customized display solutions serving the corporate enterprise, financial, healthcare, industrial and medical original equipment manufacturers markets. Our engineers design, manufacture, source and support a full spectrum of solutions to match the needs of our customers. We offer long term availability and proven custom display solutions that include touch screens, protective panels, custom enclosures, All-In-One computers, specialized cabinet finishes and application specific software packages and certification services. Our volume commitments are lower than the large display manufacturers, making us the ideal choice for companies with very specific design requirements. We partner with both private label manufacturing companies and leading branded hardware vendors to offer the highest quality display and touch solutions and customized computing platforms.

Refer to Note 7, Segment Reporting, to our unaudited consolidated financial statements for additional information on the changes in operating and reportable segments.

We currently have operations in the following major geographic regions: North America, Asia/Pacific, Europe and Latin America.

•

~~Net income during the third quarter of fiscal 2022 was $2.9 million compared to $0.2 million during the third quarter of fiscal 2021.~~

•

Net income during the second quarter of fiscal 2023 was $5.5 million compared to $4.1 million during the second quarter of fiscal 2022.

Financial Summary – ~~Nine~~Six Months Ended ~~February~~November 26, 2022

•

The first six months of fiscal 2023 and fiscal 2022 each contained 26 weeks.

•

Net sales during the first six months of fiscal 2023 were $133.5 million, an increase of 23.9%, compared to net sales of $107.7 million during the first six months of fiscal 2022.

•

Gross margin increased to 33.6% during the first six months of fiscal 2023 compared to 31.5% during the first six months of fiscal 2022.

•

Selling, general and administrative expenses were $28.9 million or 21.7% of net sales, during the first six months of fiscal 2023 compared to $26.6 million, or 24.7% of net sales, during the first six months of fiscal 2022.

•

Operating income during the first six months of fiscal 2023 was $16.0 million compared to $7.3 million during the first six months of fiscal 2022.

•

Net income during the six months of fiscal 2023 was $11.9 million compared to $6.8 million during the first six months of fiscal 2022.

As previously disclosed, we made certain changes in our reporting structure for fiscal 2023. As a result of these changes, we revised our reportable segments as further discussed in Note 7, Segment Reporting,to our unaudited consolidated financial statements. For comparability purposes, segment reporting for the prior periods have been adjusted to conform to the current presentation.

•

~~The first nine months of fiscal 2022 and fiscal 2021 each contained 39 weeks.~~

•

~~Net sales during the first nine months of fiscal 2022 were $163.0 million, an increase of 28.9%, compared to net sales of $126.5 million during the first nine months of fiscal 2021.~~

•

~~Gross margin decreased to 31.6% during the first nine months of fiscal 2022 compared to 33.6% during the first nine months of fiscal 2021.~~

•

Selling, general and administrative expenses were $40.6 million or 24.9% of net sales, during the first nine months of fiscal 2022 compared to $41.9 million, including the $1.6 million legal settlement, or 33.2% of net sales, during the first nine months of fiscal 2021.

•

~~Operating income during the first nine months of fiscal 2022 was $11.0 million compared to $0.6 million during the first nine months of fiscal 2021.~~

•

~~Net income during the first nine months of fiscal 2022 was $9.6 million compared to a net loss of $0.2 million during the first nine months of fiscal 2021.~~

Net Sales and Gross Profit Analysis

Net sales by segment and percent change during the ~~third~~second quarter and first ~~nine~~six months of fiscal ~~2022~~2023 and fiscal ~~2021~~2022 were as follows (in thousands):


Net Sales	Three Months Ended				FY22 vs. FY21			Three Months Ended				FY23 vs. FY22
	February 26, 2022		February 27, 2021		% Change			November 26, 2022		November 27, 2021		% Change
PMT	$	44,032	$	35,237		25.0	%	$	40,585	$	36,826		10.2	%
GES									12,293		4,911		150.3	%
Canvys		8,141		7,078		15.0	%		10,079		9,150		10.2	%
Healthcare		3,135		2,920		7.4	%		2,948		3,092		-4.7	%
Total	$	55,308	$	45,235		22.3	%	$	65,905	$	53,979		22.1	%

Nine Months Ended

FY22 vs. FY21

February 26, 2022

February 27, 2021

% Change

PMT

$
128,778

$
98,418

30.8
%
Canvys

25,732

20,491

25.6
%
Healthcare

8,481

7,556

12.2
%
Total

$
162,991

$
126,465

28.9
%


	Six Months Ended				FY23 vs. FY22
	November 26, 2022		November 27, 2021		% Change
PMT	$	85,939	$	77,261		11.2	%
GES		20,804		7,485		177.9	%
Canvys		20,492		17,591		16.5	%
Healthcare		6,227		5,346		16.5	%
Total	$	133,462	$	107,683		23.9	%

During the ~~third~~second quarter of fiscal ~~2022,~~2023, consolidated net sales increased ~~22.3%~~22.1% compared to the ~~third~~second quarter of fiscal ~~2021.~~2022. Sales for PMT increased ~~25.0%~~10.2%, sales for GES increased 150.3%, sales for Canvys increased ~~15.0%~~10.2% and sales for Healthcare ~~increased 7.4%~~decreased 4.7%. The increase in PMT was mainly due to strong growth ~~from our Power~~in both the semi-wafer fabrication industry and the RF and Microwave ~~new technology partners~~products. The increase in ~~various applications including Power Management~~GES was mainly due to growth in our ULTRA3000 and ~~5G infrastructure as well as increased shipments of our ULTRA3000. We~~other related product sales into the wind turbine industry and from customers manufacturing synthetic diamonds. GES also had ~~growth in various Electron Device product lines.~~increased sales into the Electric Vehicle market including electric cars and locomotives. The increase in Canvys was primarily due to strong sales in the ~~European and~~ North American ~~markets.~~market. The ~~increase~~decrease in Healthcare was ~~primarily~~ due to ~~increases in~~lower part sales which were partially offset by increased sales of equipment and ~~an increase in demand for the ALTA750~~^TMCT tubes.

During the first ~~nine~~six months of fiscal ~~2022,~~2023, consolidated net sales increased ~~28.9%~~23.9% compared to the first ~~nine~~six months of fiscal ~~2021.~~2022. Sales for PMT increased ~~30.8%~~11.2%, sales for GES increased 177.9%, sales for Canvys increased ~~25.6%~~16.5% and sales for Healthcare increased ~~12.2%~~16.5%. The increase in PMT was mainly due to strong growth in the semi-wafer fabrication industry. The increase in GES was mainly due to growth in our ULTRA3000 and other related product sales into the wind turbine industry and from ~~our Power and Microwave new technology partners in various applications including Power Management and 5G infrastructure and increased revenue from our Semiconductor Wafer Fabrication~~ customers ~~buying engineered solutions. We~~manufacturing synthetic diamonds. GES also had ~~growth in various Electron Device product lines.~~increased sales into the Electric Vehicle market including electric cars and locomotives. The increase in Canvys was primarily due to strong sales in the ~~European and~~ North American ~~markets.~~market. The increase in Healthcare was ~~primarily~~ due to ~~an increase~~increased sales in ~~demand for the ALTA750~~^TM ~~tubes.~~all major products lines.

Gross profit by segment and percent of net sales for the ~~third~~second quarter and first ~~nine~~six months of fiscal ~~2022~~2023 and fiscal ~~2021~~2022 were as follows (in thousands):


Gross Profit	Three Months Ended										Three Months Ended
	February 26, 2022		% of Net Sales			February 27, 2021		% of Net Sales			November 26, 2022		% of Net Sales			November 27, 2021		% of Net Sales
PMT	$	14,163		32.2	%	$	12,308		34.9	%	$	14,011		34.5	%	$	12,399		33.7	%
GES												4,162		33.9	%		1,587		32.3	%
Canvys		2,618		32.2	%		2,493		35.2	%		2,995		29.7	%		2,912		31.8	%
Healthcare		788		25.1	%		965		33.0	%		683		23.2	%		759		24.5	%
Total	$	17,569		31.8	%	$	15,766		34.9	%	$	21,851		33.2	%	$	17,657		32.7	%


	Six Months Ended
	November 26, 2022		% of Net Sales			November 27, 2021		% of Net Sales
PMT	$	29,546		34.4	%	$	24,586		31.8	%
GES		7,184		34.5	%		2,331		31.1	%
Canvys		6,261		30.6	%		5,730		32.6	%
Healthcare		1,887		30.3	%		1,307		24.4	%
Total	$	44,878		33.6	%	$	33,954		31.5	%

Nine Months Ended

February 26, 2022

% of Net Sales

February 27, 2021

% of Net Sales

PMT

$
41,080

31.9
%

$
33,530

34.1
%
Canvys

8,348

32.4
%

7,156

34.9
%
Healthcare

2,095

24.7
%

1,782

23.6
%
Total

$
51,523

31.6
%

$
42,468

33.6
%

Gross profit reflects the distribution and manufacturing product margin less manufacturing variances, inventory obsolescence charges, customer returns, scrap and cycle count adjustments, engineering costs and other provisions.

Consolidated gross profit increased to ~~$17.6~~$21.9 million during the ~~third~~second quarter of fiscal ~~2022~~2023 compared to ~~$15.8~~$17.7 million during the ~~third~~second quarter of fiscal ~~2021.~~2022. Consolidated gross margin as a percentage of net sales ~~decreased~~increased to ~~31.8%~~33.2% during the ~~third~~second quarter of fiscal ~~2022~~2023 from ~~34.9%~~32.7% during the ~~third~~second quarter of fiscal ~~2021,~~2022, primarily due to product mix in PMT ~~higher freight costs~~and product mix and manufacturing efficiencies in GES. The unfavorable product mix and foreign currency effects in Canvys and ~~increased component scrap expense~~unfavorable product mix in Healthcare partially offset the favorable gross margin impact for PMT and ~~higher freight costs in Healthcare.~~GES.

Consolidated gross profit increased to ~~$51.5~~$44.9 million during the first ~~nine~~six months of fiscal ~~2022~~2023 compared to ~~$42.5~~$34.0 million during the first ~~nine~~six months of fiscal ~~2021.~~2022. Consolidated gross margin as a percentage of net sales ~~decreased~~increased to ~~31.6% during the first nine months of fiscal 2022 from~~ 33.6% during the first ~~nine~~six months of fiscal ~~2021,~~2023 from 31.5% during the first six months of fiscal 2022, primarily due to product mix in PMT, product mix and ~~higher freight costs~~manufacturing efficiencies in ~~Canvys.~~GES, and decreased component scrap expense and improved manufacturing absorption in Healthcare. The unfavorable product mix and foreign currency effects in Canvys partially offset the favorable gross margin impact for PMT, GES and Healthcare.

Power and Microwave Technologies ~~Group~~

PMT net sales increased ~~25.0%~~10.2% to ~~$44.0~~$40.6 million during the ~~third~~second quarter of fiscal ~~2022~~2023 from ~~$35.2~~$36.8 million during the ~~third~~second quarter of fiscal ~~2021.~~2022. The increase was mainly due to strong growth ~~from our Power~~in both the semi-wafer fabrication industry and the RF and Microwave ~~new technology partners~~products for various applications. Gross margin as a percentage of net sales increased to 34.5% during the second quarter of fiscal 2023 as compared to 33.7% during the second quarter of fiscal 2022 due to product mix.

PMT net sales increased 11.2% to $85.9 million during the first six months of fiscal 2023 from $77.3 million during the first six months of fiscal 2022. The increase was mainly due to strong growth in ~~various applications including Power Management~~the semi-wafer fabrication industry. Gross margin as a percentage of net sales increased to 34.4% during the first six months of fiscal 2023 as compared to 31.8% during the first six months of fiscal 2022 due to product mix.

Green Energy Solutions

GES net sales increased 150.3% to $12.3 million during the second quarter of fiscal 2023 from $4.9 million during the second quarter of fiscal 2022. The increase was mainly due to growth in our ULTRA3000 and ~~5G infrastructure as well as increased shipments of our ULTRA3000.~~other related product sales into the wind turbine industry and from customers manufacturing synthetic diamonds. We also ~~had~~saw an increase in sales into the Electric Vehicle market including both electric cars and locomotives. Gross margin as a percentage of net sales increased to 33.9% during the second quarter of fiscal 2023 as compared to 32.3% during the second quarter of fiscal 2022 due to improved manufacturing efficiencies and product mix.

GES net sales increased 177.9% to $20.8 million during the first six months of fiscal 2023 from $7.5 million during the first six months of fiscal 2022. The increase was mainly due to growth in ~~various Electron Device~~our ULTRA3000 and other related product ~~lines.~~sales into the wind turbine industry and from customers manufacturing synthetic diamonds. We also saw an increase in sales into the Electric Vehicle market including both electric cars and locomotives. Gross margin as a percentage of net sales increased to 34.5% during the first six months of fiscal 2023 as compared to 31.1% during the first six months of fiscal 2022 due to improved manufacturing efficiencies and product mix.

Canvys

Canvys net sales increased 10.2% to $10.1 million during the second quarter of fiscal 2023 from $9.2 million during the second quarter of fiscal 2022, primarily due to strong sales in the North American market. Gross margin as a percentage of net sales decreased to ~~32.2%~~29.7% during the ~~third~~second quarter of fiscal 2023 from 31.8% during the second quarter of fiscal 2022 ~~as compared to 34.9% during the third quarter of fiscal 2021~~primarily due to product ~~mix.~~mix and foreign currency effects.

~~PMT~~Canvys net sales increased ~~30.8%~~16.5% to ~~$128.8~~$20.5 million during the first ~~nine~~six months of fiscal 2023 from $17.6 million during the first six months of fiscal 2022 ~~from $98.4 million during the first nine months of fiscal 2021. The increase was mainly~~primarily due to strong ~~growth from our Power and Microwave new technology partners~~sales in various applications including Power Management and 5G infrastructure and increased revenue from our Semiconductor Wafer Fabrication customers buying engineered solutions. We also had growth in various Electron Device product lines.the North American market. Gross margin as a percentage of net sales decreased to ~~31.9%~~30.6% during the first ~~nine~~six months of fiscal 2023 from 32.6% during the first six months of fiscal 2022 ~~as compared to 34.1% during the first nine months of fiscal 2021~~primarily due to product ~~mix.~~mix and foreign currency effects.

~~Canvys~~Healthcare

~~Canvys~~Healthcare net sales ~~increased 15.0%~~decreased 4.7% to ~~$8.1~~$2.9 million during the ~~third~~second quarter of fiscal 2023 from $3.1 million during the second quarter of fiscal 2022 ~~from $7.1 million during the third quarter of fiscal 2021 primarily~~ due to ~~strong sales in the European as well as the North American markets. Gross margin as~~ a percentage of net sales decreased to 32.2% during the third quarter of fiscal 2022 from 35.2% during the third quarter of fiscal 2021 due to the increasing freight costs resulting from the COVID-19 pandemic.

Canvys net sales increased 25.6% to $25.7 million during the first nine months of fiscal 2022 from $20.5 million during the first nine months of fiscal 2021 primarily due to strong sales in the European as well as the North America markets. Gross margin as a percentage of net sales decreased to 32.4% during the first nine months of fiscal 2022 from 34.9% during the first nine months of fiscal 2021 due to the increasing freight costs resulting from the COVID-19 pandemic.

~~Healthcare~~

~~Healthcare net sales increased 7.4% to $3.1 million during the third quarter of fiscal 2022 from $2.9 million during the third quarter of fiscal 2021 primarily due to increases~~decrease in part sales ~~as well as an increase~~partially offset by increases in ~~demand for the ALTA750~~^TMequipment sales and CT tubes. Gross margin as a percentage of net sales decreased to ~~25.1%~~23.2% during the ~~third~~second quarter of fiscal 2023 as compared to 24.5% during the second quarter of fiscal 2022 ~~as compared to 33.0% during the third quarter of fiscal 2021~~ primarily due to ~~increased component scrap expense in addition to rising freight costs resulting from the COVID-19 pandemic.~~product mix.

Healthcare net sales increased ~~12.2%~~16.5% to ~~$8.5~~$6.2 million during the first ~~nine~~six months of fiscal 2023 from $5.3 million during the first six months of fiscal 2022 ~~from $7.6 million during the first nine months of fiscal 2021. The increase in sales was primarily~~ due to ~~an increase~~increases in ~~demand for the ALTA750~~^TM ~~tubes.~~all major Healthcare product lines. Gross margin as a percentage of net sales increased to ~~24.7%~~30.3% during the first ~~nine~~six months of fiscal 2023 as compared to 24.4% during the first six months of fiscal 2022 ~~as compared to 23.6% during the first nine months of fiscal 2021~~ primarily due to ~~favorable product mix partially offset by rising freight costs resulting from the COVID-19 pandemic.~~ improved manufacturing absorption and decreased component scrap expense.

~~Legal Settlement – Fiscal 2021~~

On April 2, 2021, as part of a settlement where the Company did not admit liability, Richardson agreed to pay Varex Imaging Corporation (“Varex”) $1.6 million to settle those claims. This settlement was recorded in selling, general and administrative expenses within the Consolidated Statements of Comprehensive Income for the third quarter of fiscal 2021.

Selling, General and Administrative Expenses

Selling, general and administrative expenses ~~decreased~~(“SG&A”) increased to ~~$13.9~~$14.7 million during the ~~third~~second quarter of fiscal ~~2022~~2023 from ~~$15.5~~$13.1 million in the ~~third~~second quarter of fiscal ~~2021.~~2022. The ~~decrease~~increase was mainly due to ~~the non-recurrence in fiscal 2022 of the $1.6 million legal settlement recorded in fiscal 2021. The foregoing section discusses the fiscal 2021 legal settlement. In addition,~~ higher employee compensation expenses, ~~were offset by lower legal fees.~~including incentive expense from higher operating income and higher travel expenses. However, as a percentage of net sales, SG&A for the second quarter of fiscal 2023 decreased to 22.3% compared to 24.3% for the second quarter of fiscal 2022.

Selling, general and administrative expenses ~~decreased~~increased to ~~$40.6~~$28.9 million during the first ~~nine~~six months of fiscal ~~2022~~2023 from ~~$41.9~~$26.6 million in the first ~~nine~~six months of fiscal ~~2021.~~2022. The ~~decrease~~increase was mainly due to ~~the non-recurrence in fiscal 2022 of the $1.6 million legal settlement recorded in fiscal 2021. The foregoing section discusses the fiscal 2021 legal settlement. In addition,~~ higher employee compensation expenses, ~~were partially offset by lower legal fees.~~including incentive expense from higher operating income and higher travel expenses. However, as a percentage of net sales, SG&A for the first six months of fiscal 2023 decreased to 21.7% compared to 24.7% for the first six months of fiscal 2022.

Other Income/Expense

Other expense was $0.1 million during the ~~third~~second quarter of fiscal ~~2022,~~2023, compared to ~~less than $0.1~~other income of $0.2 million for the ~~third~~second quarter of fiscal ~~2021.~~2022. Other expense during the ~~third~~second quarter of fiscal ~~2022~~2023 was mainly aattributable to foreign ~~exchange loss, as investment income was offset by other expenses.~~exchange. Our foreign exchange gains and losses are primarily due to the translation of U.S. dollars held in non-U.S. entities. We currently do not utilize derivative instruments to manage our exposure to foreign currency.

Other expense was ~~less than $0.1~~$0.5 million during the first ~~nine~~six months of fiscal ~~2022,~~2023, compared to ~~$0.5~~other income of $0.1 million for the first ~~nine~~six months of fiscal ~~2021. For~~2022. Other expense during the first ~~nine~~six months of fiscal ~~2022 investment income~~2023 was ~~more than offset by other expenses and the~~mainly attributable to foreign exchange. Our foreign exchange ~~gain was minimal.~~gains and losses are primarily due to the translation of U.S. dollars held in non-U.S. entities. We currently do not utilize derivative instruments to manage our exposure to foreign currency.

Income Tax Provision

The income tax provision was ~~$0.6~~$1.5 million and ~~$0.1~~$0.6 million for the ~~third~~second quarter of fiscal 2023 and for the second quarter of fiscal 2022, ~~and~~respectively. The effective income tax rate during the ~~third~~second quarter of fiscal ~~2021, respectively.~~2023 was a tax provision of 21.5% as compared to a tax provision of 11.8% during the second quarter of fiscal 2022. The difference in rate during the ~~tax provision for~~second quarter of fiscal 2023 as compared to the ~~third~~second quarter of fiscal 2022 ~~as compared to~~reflects changes in the ~~third quarter~~valuation allowance recorded at year end fiscal 2022, absence of Net Operating Losses (“NOL”) for utilization in fiscal ~~2021 reflects higher foreign taxes, changes in~~2023, our geographical distribution of income (loss), which is primarily driven by an increase in U.S. earnings for fiscal 2023 and a state income tax ~~provision due to temporary suspension of net operating loss utilization in Illinois and California.~~provision.

We recorded an income tax provision of ~~$1.3~~$3.6 million and ~~$0.2~~$0.7 million for the first ~~nine~~six months of fiscal 2023 and the first six months of fiscal 2022, ~~and~~respectively. The effective income tax rate during the first ~~nine~~six months of fiscal ~~2021, respectively.~~2023 was a tax provision of 23.4% as compared to a tax provision of 9.6% during the first six months of fiscal 2022. The difference in ~~the tax provision for~~rate during the first ~~nine~~six months of fiscal ~~2022~~2023 as compared to the first ~~nine~~six months of fiscal ~~2021~~2022 reflects ~~higher foreign taxes,~~ changes in the valuation allowance recorded at year end fiscal 2022, absence of Net Operating Losses (“NOL”) for utilization in fiscal 2023, our geographical distribution of income (loss), which is primarily driven by an increase in U.S. earnings for fiscal 2023 and a state income tax ~~provision due to temporary suspension~~provision. The 23.4% effective income tax rate differs from the federal statutory rate of ~~net operating loss utilization~~21% as a result of our geographical distribution of income (loss), which is primarily driven by an increase in ~~Illinois~~U.S. earnings for fiscal 2023 and ~~California.~~a state income tax provision.

In the normal course of business, we are subject to examination by taxing authorities throughout the world. Generally, years prior to fiscal ~~2015~~2017 are closed for examination under the statute of limitation for U.S. federal, U.S. state and local or non-U.S. tax jurisdictions. We ~~are currently~~were under examination ~~in Thailand (fiscal 2008 through 2011) and Germany (fiscal~~for fiscal 2015 through ~~2018).~~fiscal 2018 in Germany. The audit was settled in the fourth quarter of fiscal 2022. In the second quarter of fiscal 2023, the Company paid the audit assessment for the fiscal 2015 through fiscal 2018 years. Our primary foreign tax jurisdictions are Germany and the Netherlands. We have tax years open in Germany beginning in fiscal ~~2015~~2019 and the Netherlands beginning in fiscal ~~2018.~~2021.

Net Income ~~(Loss)~~ and Per Share Data

Net income during the ~~third~~second quarter of fiscal ~~2022~~2023 was ~~$2.9~~$5.5 million, or ~~$0.21~~$0.39 per diluted common share and ~~$0.19~~$0.35 per Class B diluted common share as compared to ~~$0.2~~$4.1 million during the ~~third~~second quarter of fiscal ~~2021~~2022 or ~~$0.02~~$0.30 per diluted common share and ~~$0.02~~$0.27 per Class B diluted common share.

Net income during the first ~~nine~~six months of fiscal ~~2022~~2023 was ~~$9.6~~$11.9 million, or ~~$0.71~~$0.83 per diluted common share and ~~$0.64~~$0.75 per Class B diluted common share as compared to ~~net loss of $0.2~~$6.8 million during the first ~~nine~~six months of fiscal ~~2021~~2022 or ~~($0.02)~~$0.50 per diluted common share and ~~($0.02)~~$0.45 per Class B diluted common share.

LIQUIDITY, FINANCIAL POSITION AND CAPITAL RESOURCES

Our operations and cash needs have been primarily financed through income from operations and cash on hand.

Cash, ~~and~~ cash equivalents and investments were ~~$39.1~~$31.1 million at ~~February~~November 26, 2022. Cash, ~~and~~ cash equivalents and investments by geographic area at ~~February~~November 26, 2022 consisted of ~~$25.2~~$13.7 million in North America, ~~$7.1~~$9.1 million in Europe, $1.4 million in Latin America and ~~$5.4~~$6.9 million in Asia/Pacific. No funds were repatriated to the United States in the first six months of fiscal 2023. However, we anticipate repatriation of funds to the United States in subsequent quarters. Although the Tax Cuts and Jobs Act generally eliminated federal income tax on future cash repatriation to the United States, cash repatriation may be subject to state and local taxes, withholding or similar taxes. See Note 7, Income Taxes of the notes to our consolidated financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended May 28, 2022, filed with the SEC on August 1, 2022 for further information.

Cash, cash equivalents and investments were $40.5 million at May 28, 2022. Cash, cash equivalents and investments by geographic area at May 28, 2022 consisted of $25.7 million in North America, $6.0 million in Europe, $1.5 million in Latin America and $7.3 million in Asia/Pacific. We repatriated a total of $1.5 million to the United States in fiscal ~~2022.~~2022 from our foreign entities. This amount includes $0.7 million in the first quarter from our entity in China, $0.3 million in the second quarter from our entity in Taiwan and $0.5 million in the third quarter from our entity in Japan. ~~Although the Tax Cuts~~

Our short-term and ~~Jobs Act generally eliminated federal income tax~~long-term liquidity requirements primarily arise from: (i) working capital requirements, (ii) capital expenditure needs and (iii) cash dividend payments (if and when declared by our Board of Directors). Our ability to fund these requirements will depend, in part, on our future cash ~~repatriation to the United States, cash repatriation may be~~flows, which are determined by our future operating performance and, therefore, subject to ~~state~~prevailing global macroeconomic conditions and ~~local taxes, withholding or similar taxes. See Note 7,~~ ~~Income Taxes~~financial, business and other factors, some of ~~the notes to~~which are beyond our ~~consolidated financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended May 29, 2021, filed August 2, 2021 for further information.~~

Cash and cash equivalents were $43.3 million at May 29, 2021. Cash and cash equivalents by geographic area at May 29, 2021, consisted of $26.1 million in North America, $8.8 million in Europe, $1.2 million in Latin America and $7.2 million in Asia/Pacific. We repatriated a total of $0.9 million to the United States in fiscal 2021 from several of our foreign entities. This amount includes $0.7 million from our entities in Italy and South Korea in the third quarter of fiscal 2021 and $0.2 million from our entity in France in the fourth quarter of fiscal 2021.

control. The Company continues to monitor the impact of COVID-19, including the extent, duration and effectiveness of containment actions taken, the speed and extent of vaccination programs, ~~as well as other global developments (including geopolitical tensions and~~ the ~~current conflict between Ukraine and Russia) and their~~ impact of the pandemic on ~~the Company’s~~its supply chain, manufacturing and distribution operations, customers and employees, as well as the U.S. ~~and world~~ economy in general. However, due to the uncertain and constantly evolving impacts of the COVID-19 pandemic ~~and other disruptions that have created extreme volatility in the capital markets and may continue to have further global economic consequences~~ across the globe, the Company cannot currently predict the long-term impact on its operations and financial results. The uncertainties associated with the COVID-19 pandemic and its effects ~~along with other global volatility,~~ include potential adverse effects on the overall economy, the ~~Company's~~Company’s supply chain, transportation services, employees and ~~customers, as well as~~customers. The COVID-19 pandemic and its effects could adversely affect the ~~Company's~~Company’s revenues, earnings, liquidity and cash flows and may require significant actions in response, including expense reductions. Conditions surrounding COVID-19 ~~and other matters of global concern~~ change rapidly and additional impacts of which the Company is not currently aware may arise. Based on past performance and current expectations, we believe that the existing sources of liquidity, including current cash, will provide sufficient resources to meet known capital requirements and working capital needs through the next twelve ~~months~~.months. Additionally, while our future capital requirements will depend on many factors, including, but not limited to, the economy and the outlook for growth in our markets, we believe our existing sources of liquidity as well as our ability to generate operating cash flows will satisfy our future obligations and cash requirements.

Cash Flows from Operating Activities

Cash flows from operating activities primarily resulted from our net income ~~(loss)~~ adjusted for non-cash items and changes in our operating assets and liabilities.

Operating activities used ~~$1.5~~$7.2 million of cash during the first ~~nine~~six months of fiscal ~~2022.~~2023. We had a net income of ~~$9.6~~$11.9 million during the first ~~nine~~six months of fiscal ~~2022,~~2023, which included non-cash stock-based compensation expense of $0.5 million associated with the issuance of stock option and restricted stock awards, inventory reserve provisions of $0.2 million and depreciation and amortization expense of ~~$2.6~~$1.8 million associated with our property and equipment as well as amortization of our intangible assets. Changes in our operating assets and liabilities used ~~$14.4~~$21.5 million in cash during the first ~~nine~~six months of fiscal 2023, net of foreign currency exchange gains and losses, included an increase in accounts receivable of $5.5 million, an increase in inventory of $18.1 million and an increase in prepaid expenses of $0.4 million. Partially offsetting the cash utilization for accounts receivable, inventory and prepaid expenses was an increase in accounts payable and accrued liabilities of $1.9 million. The increase in accounts receivable was primarily due to increased sales. The majority of the inventory increase was to support the product growth in LaFox manufacturing, Green Energy Solutions and Canvys, in addition to increases in the inventory for electron tubes. The increase in accounts payable was related to the inventory increase and the increase in accrued liabilities was timing related.

Operating activities used $0.2 million of cash during the first six months of fiscal 2022. We had a net income of $6.8 million during the first half of fiscal 2022, which included non-cash stock-based compensation expense of $0.4 million associated with the issuance of stock option and restricted stock awards, $0.1 million for inventory reserve provisions and depreciation and amortization expense of $1.7 million associated with our property and equipment as well as amortization of our intangible assets. Changes in our operating assets and liabilities used $9.2 million in cash during the first six months of fiscal 2022, net of foreign currency exchange gains and losses, included an increase in accounts receivable of ~~$7.4~~$3.1 million, an increase in inventory of ~~$12.3~~$9.2 million and an increase in prepaid expenses of $1.1 million. Partially offsetting the cash utilization for accounts receivable, inventory and prepaid expenses was an increase in accounts payable and accrued liabilities of ~~$6.3~~$3.8 million. The increase in accounts receivable was primarily due to increased ~~sales.~~sales revenue. The majority of the inventory increase was to support the growth in LaFox manufacturing and the RF and microwave components business. The increase in accounts payable was related to the inventory increase and the increase in accrued liabilities was timing related.

Operating activities provided $3.9 million of cash during the first nine months of fiscal 2021. We had a net loss of $0.2 million during the first nine months of fiscal 2021, which included non-cash stock-based compensation expense of $0.5 million associated with the issuance of stock option and restricted stock awards, $0.7 million for inventory reserve provisions and depreciation and amortization expense of $2.6 million associated with our property and equipment as well as amortization of our intangible assets. Changes in our operating assets and liabilities resulted in cash provided of $0.3 million during the first nine months of fiscal 2021, net of foreign currency exchange gains and losses, included an increase in accrued liabilities of $4.3 million, partially offset by a decrease of $2.0 million in accounts payable, an increase in accounts receivable of $1.0 million and an increase in inventory of $0.9 million. The increase in accrued liabilities was mainly due to a legal settlement and timing of employee compensation and payroll tax payments as well as the timing of other payments. The decrease in our accounts payable was due to timing of payments for some of our larger vendors for both inventory and services. The increase in accounts receivable was primarily due to the sales increase in fiscal 2021. The majority of the inventory increase was to support the electron tube and RF and microwave components business.

Cash Flows from Investing Activities

Cash flows from investing activities consisted primarily of capital expenditures and purchases and maturities of investments. Our purchases and proceeds from investments consist of time deposits and CDs. The purchasing of future investments varies from period to period due to interest and foreign currency exchange rates.

Cash used in investing activities of ~~$2.2~~$2.6 million during the first ~~nine~~six months of fiscal 2023 was mainly due to capital expenditures. Capital expenditures were primarily related to our IT system, as well as our LaFox manufacturing business and facilities, which also supports both EDG and Green Energy Solutions. The Company did not have any investment purchases or maturities in the first six months of fiscal 2023.

Cash used in investing activities of $1.6 million during the first six months of fiscal 2022 was due to capital expenditures. Capital expenditures ~~were~~related primarily ~~related~~ to capital used for our Healthcare business, IT system and manufacturing facilities. The Company did not have any investment purchases or maturities in the first ~~nine months~~half of fiscal 2022.

Cash provided by investing activities of $5.2 million during the first nine months of fiscal 2021 included proceeds from the maturities of investments of $16.0 million, partially offset by purchases of investments of $9.0 million and $1.8 million in capital expenditures. Capital expenditures were primarily related to our Healthcare business and IT system.

Cash Flows from Financing Activities

Cash flows used in financing activities consisted primarily of cash dividends and cash flows provided by financing activities consisted primarily of the proceeds from the issuance of stock.

Cash provided by financing activities of ~~$0.1~~$1.2 million during the first ~~nine~~six months of fiscal ~~2022~~2023 primarily resulted from the ~~$2.6~~$2.9 million proceeds from the issuance of stock less the ~~$2.4~~$1.7 million of dividend payments to stockholders.

Cash used in financing activities of ~~$2.5~~$0.9 million during the first ~~nine~~six months of fiscal ~~2021 primarily resulted~~2022 were due to dividend payments of $1.6 million with a partial offset for the proceeds from ~~cash used to pay dividends.~~the issuance of stock of $0.7 million.

All future payments of dividends are at the discretion of the Board of Directors. Dividend payments will depend on earnings, capital requirements, operating conditions and such other factors that the Board may deem relevant.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

~~ITEM 3.~~

~~QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK~~

Risk Management and Market Sensitive Financial Instruments

We are exposed to many different market risks with the various industries we serve. The primary financial risk we are exposed to is foreign currency exchange, as certain operations, assets and liabilities of ours are denominated in foreign currencies. We manage these risks through normal operating and financing activities.

The interpretation and analysis of these disclosures should not be considered in isolation since such variances in exchange rates would likely influence other economic factors. Such factors, which are not readily quantifiable, would likely also affect our operations. Additional disclosure regarding various market risks are set forth in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended May ~~29, 2021,~~28, 2022, filed with the SEC on August ~~2, 2021.~~1, 2022.

ITEM 4. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

~~ITEM 4.~~

~~CONTROLS AND PROCEDURES~~

~~(a)~~

~~Evaluation of Disclosure Controls and Procedures~~

Management of the Company, with the participation of the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of ~~February~~November 26, 2022.

Disclosure controls and procedures are intended to provide reasonable assurance that information required to be disclosed in the Company’s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.

(b) Changes in Internal Control over Financial Reporting

~~(b)~~

~~Changes in Internal Control over Financial Reporting~~

There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during the ~~third~~second quarter of fiscal ~~2022~~2023 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

~~LEGAL PROCEEDINGS~~

ITEM 1A. RISK FACTORS

~~ITEM 1A.~~

~~RISK FACTORS~~

There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended May ~~29, 2021,~~28, 2022, filed with the SEC on August ~~2, 2021.~~1, 2022.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

~~UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS~~

ITEM 5. OTHER INFORMATION

~~OTHER INFORMATION~~

ITEM 6. EXHIBITS

~~EXHIBITS~~

Exhibit Index


Exhibit Number		Description

3.1		Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Annex III of the Proxy Statement dated August 22, 2014).

3.2		Amended and Restated By-Laws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 15, 2017).
31.1		Certification of Edward J. Richardson pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Robert J. Ben pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32		Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		The following financial information from our Quarterly Report on Form 10-Q for the ~~third~~second quarter of fiscal ~~2022,~~2023, filed with the SEC on ~~April 7, 2022,~~January 5, 2023, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Balance Sheets, (ii) the Unaudited Consolidated Statements of Comprehensive Income, (iii) the Unaudited Consolidated Statements of Cash Flows, (iv) the Unaudited Consolidated Statement of Stockholders’ Equity and (v) Notes to Unaudited Consolidated Financial Statements.

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

~~SIGNATURES~~28

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	RICHARDSON ELECTRONICS, LTD.

Date: ~~April 7, 2022~~January 5, 2023	By:	/s/ Robert J. Ben
		Robert J. Ben Chief Financial Officer and Chief Accounting Officer (on behalf of the Registrant and as Principal Financial Officer)

2829


Title of each class	Trading Symbol(s)		Name of each exchange on which registered
Common stock, $0.05 Par Value		RELL		NASDAQ Global Select Market


Large Accelerated Filer	☐	Accelerated Filer	☐☒
Non-Accelerated Filer	☒☐	Smaller Reporting Company	☒
Emerging Growth Company	☐


		Page



Part I.	Financial Information

Item 1.	Financial Statements	2
	Consolidated Balance Sheets	2
	Unaudited Consolidated Statements of Comprehensive Income	3
	Unaudited Consolidated Statements of Cash Flows	4
	Unaudited Consolidated Statement of Stockholders’ Equity	5
	Notes to Unaudited Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2526
Item 4.	Controls and Procedures	2526

Part II.	Other Information

Item 1.	Legal Proceedings	2627
Item 1A.	Risk Factors	2627
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2627
Item 5.	Other Information	2627
Item 6.	Exhibits	2728
Exhibit Index		2728
Signatures			2829

	Three Months Ended						Nine Months Ended
	February 26, 2022			February 27, 2021			February 26, 2022			February 27, 2021
Net Sales
North America	$	23,647		$	19,654		$	68,615		$	53,513
Asia/Pacific		13,275			9,821			38,220			28,970
Europe		16,067			13,285			48,231			37,277
Latin America		2,380			2,446			7,976			6,591
Other (1)		(61	)		29			(51	)		114
Total	$	55,308		$	45,235		$	162,991		$	126,465
Gross Profit
North America	$	8,946		$	8,081		$	24,984		$	21,099
Asia/Pacific		4,061			3,517			12,126			9,592
Europe		4,884			4,356			14,507			12,153
Latin America		917			896			2,998			2,345
Other (1)		(1,239	)		(1,084	)		(3,092	)		(2,721	)
Total	$	17,569		$	15,766		$	51,523		$	42,468

Fiscal Year	Amortization Expense
Remaining 2022	$	63
2023		246
2024		232
2025		219
2026		185
Thereafter		1,132
Total amortization	$	2,077

Fiscal Year	Operating Leases		Financing Leases		Total
Remaining 2022	$	338	$	15	$	353
2023		1,218		—		1,218
2024		838		—		838
2025		586		—		586
2026		401		—		401
Thereafter		94		—		94
Total lease payments		3,475		15		3,490
Less imputed interest		213		—		213
Net minimum lease payments	$	3,262	$	15	$	3,277